These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significance of increased scrotal Tc-99m MDP uptake in patients with prostate cancer. Selcuk NA, Sayman HB, Kanmaz B, Turkmen C, Selcuk H, Nisli C, Uslu I. Nucl Med Commun; 2011 Feb; 32(2):155-8. PubMed ID: 21085045 [Abstract] [Full Text] [Related]
3. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Huncharek M, Muscat J. Cancer Invest; 1995 Feb; 13(1):31-5. PubMed ID: 7530590 [Abstract] [Full Text] [Related]
9. Metastasis on bone scan with low prostate specific antigen (≤20 ng/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines? Zaman MU, Fatima N, Sajjad Z. Asian Pac J Cancer Prev; 2011 Jun; 12(6):1529-32. PubMed ID: 22126493 [Abstract] [Full Text] [Related]
10. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, Machiels JP, Vande Berg B, Omoumi P, Tombal B. Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187 [Abstract] [Full Text] [Related]
11. Is it safe to omit baseline bone scan for newly diagnosed prostate cancer patients? Wang Y, Wan F, Xu L, Zhao N, Xu Z, Wang H, Wang G, Ye D, Guo J. Urol Int; 2015 Jul; 94(3):342-6. PubMed ID: 25632890 [Abstract] [Full Text] [Related]
14. Determination of the optimal cut-off value of serum prostate-specific antigen in the prediction of skeletal metastases on technetium-99m whole-body bone scan by receiver operating characteristic curve analysis. Manohar PR, Rather TA, Khan SH. World J Nucl Med; 2020 Jul; 19(3):255-259. PubMed ID: 33354181 [Abstract] [Full Text] [Related]